Medical Therapeutics Company Announces Positive Study Results For Cancer Treatment Technology

The Hemopurifier® has earned the prestigious designation of Breakthrough Device from the U.S. Food and Drug Administration (FDA).

Aethlon Medical, Inc. (Nasdaq: AEMD), a medical therapeutic company, has recently announced a leap forward in its mission to combat cancer and life-threatening infectious diseases. The breakthrough comes in the form of positive results from an in vitro binding study of its Hemopurifier® technology, specifically focusing on its efficacy in removing extra…